Wayne Larrison, MD
Ophthalmology · New Haven, CTNPI 1033105929
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $3,890 of the $5,228 with a category attached, or 74.4%. US Retina LLC accounts for 96.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $2,697 and has fallen 94.7% since, to $143 in 2022.
Across 10 payments — averaging $522.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$5K
- Apellis Pharmaceuticals, Inc.$143
- Carl Zeiss Meditec AG$19
- Bausch & Lomb, A Division Of Bausch Health US, LLC$14
- AbbVie$13
What the payments were for
- Food & beverage$1693%
- Gifts$190%
- Ownership interest$3,89074%
- Other$1,15022%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 5 | $5,040 |
| Apellis Pharmaceuticals, Inc. | 2 | $143 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $14 |
| AbbVie | 1 | $13 |
How this compares
$5,228 in reported general payments places this provider in the 85th percentile of 279 ophthalmology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 29 | $2,069 |
| Difluprednate | 12 | $1,534 |
| Timolol Maleate | 15 | $112 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in New Haven
- Amir CohenNew Haven$266K
- Paul KangNew Haven$40K
- Brian HaflerNew Haven$15K
- James WeiszNew Haven$14K
- Kristen NwanyanwuNew Haven$12K
- Lucian del PrioreNew Haven$9K
- Gargi VoraNew Haven$7K
- James TsaiNew Haven$7K
- Sara NetterNew Haven$3K
- John HuangHartford$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.